HK1150176A1 - 穩定性冠狀動脈疾病中的風險分級方法 - Google Patents

穩定性冠狀動脈疾病中的風險分級方法

Info

Publication number
HK1150176A1
HK1150176A1 HK11104300.4A HK11104300A HK1150176A1 HK 1150176 A1 HK1150176 A1 HK 1150176A1 HK 11104300 A HK11104300 A HK 11104300A HK 1150176 A1 HK1150176 A1 HK 1150176A1
Authority
HK
Hong Kong
Prior art keywords
coronary artery
artery disease
risk stratification
stable coronary
stable
Prior art date
Application number
HK11104300.4A
Other languages
English (en)
Inventor
‧博格曼
‧斯塔克
‧莫根塔勒
‧帕帕索提里奧
‧布蘭肯比爾格
‧拉克尼爾
‧如普勒馳特
‧比克爾
Original Assignee
有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 有限公司 filed Critical 有限公司
Publication of HK1150176A1 publication Critical patent/HK1150176A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/585—Calcitonins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/323—Arteriosclerosis, Stenosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/54—Determining the risk of relapse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
HK11104300.4A 2007-08-03 2011-04-29 穩定性冠狀動脈疾病中的風險分級方法 HK1150176A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07015271A EP2020603A1 (en) 2007-08-03 2007-08-03 Method for risk stratification in stable coronary artery disease
PCT/EP2008/006378 WO2009018979A1 (en) 2007-08-03 2008-08-01 Method for risk stratification in stable coronary artery disease

Publications (1)

Publication Number Publication Date
HK1150176A1 true HK1150176A1 (zh) 2011-11-04

Family

ID=38480646

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11104300.4A HK1150176A1 (zh) 2007-08-03 2011-04-29 穩定性冠狀動脈疾病中的風險分級方法

Country Status (7)

Country Link
US (3) US8735079B2 (zh)
EP (2) EP2020603A1 (zh)
JP (1) JP5385270B2 (zh)
CN (1) CN101932940B (zh)
ES (2) ES2400022T3 (zh)
HK (1) HK1150176A1 (zh)
WO (1) WO2009018979A1 (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2020603A1 (en) 2007-08-03 2009-02-04 BRAHMS Aktiengesellschaft Method for risk stratification in stable coronary artery disease
ATE533061T1 (de) 2007-08-03 2011-11-15 Brahms Gmbh Verfahren zur diagnose bakterieller infektionen
DK2425259T3 (en) * 2009-04-28 2018-04-30 Brahms Gmbh IMMUNOASSAY TO DETECT PROCALCITONIN
JP5753159B2 (ja) * 2009-05-05 2015-07-22 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 内皮性機能／機能不全に関連した疾患に罹患している患者の血管作動性ホルモンに基づいた層化
DK2470910T3 (en) 2009-08-28 2017-04-03 Brahms Gmbh Procalcitonin for the prognosis of side effects
ES2601104T3 (es) * 2009-10-13 2017-02-14 B.R.A.H.M.S Gmbh Procalcitonina para el diagnóstico de infecciones bacterianas y la guía del tratamiento antibiótico en pacientes con apoplejía aguda o accidente isquémico transitorio
WO2011157446A1 (en) * 2010-06-18 2011-12-22 B.R.A.H.M.S Gmbh Biomarkers for the prediction of incident cancer
RU2618437C2 (ru) * 2010-11-01 2017-05-03 Б.Р.А.Х.М.С Гмбх Оценка прогноза и риска пациентов с неспецифическими жалобами
EP2538360A1 (en) 2011-06-16 2012-12-26 Koninklijke Philips Electronics N.V. Method of predicting a blood dilution risk value
US20150090010A1 (en) * 2013-09-27 2015-04-02 Chang Gung University Method for diagnosing heart failure
US10260111B1 (en) 2014-01-20 2019-04-16 Brett Eric Etchebarne Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample
EP3180621B1 (en) 2014-08-14 2020-04-01 Memed Diagnostics Ltd. Computational analysis of biological data using manifold and a hyperplane
US11143659B2 (en) 2015-01-27 2021-10-12 Arterez, Inc. Biomarkers of vascular disease
CN108699583B (zh) 2016-03-03 2022-11-01 米密德诊断学有限公司 用于区分细菌和病毒感染的rna决定子
CA3027341A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
US11340223B2 (en) 2016-07-10 2022-05-24 Memed Diagnostics Ltd. Early diagnosis of infections
US11353456B2 (en) * 2016-09-29 2022-06-07 Memed Diagnostics Ltd. Methods of risk assessment and disease classification for appendicitis
US10415094B2 (en) 2016-10-06 2019-09-17 HelicalHelp LLC Risk stratification method for a patient having a polymorphism
US20200261549A1 (en) * 2017-11-07 2020-08-20 Alphacore Pharma Llc Methods of treating and protecting against cardiac disease, cardiovascular disease and related conditions and symptoms
EA035661B1 (ru) * 2018-04-02 2020-07-23 Республиканский научно-практический центр "Кардиология" Способ прогнозирования сердечно-сосудистых осложнений раннего послеоперационного периода у пациентов с ишемической болезнью сердца с исходно сниженной сократительной функцией левого желудочка после операции на открытом сердце
CN111834008A (zh) * 2020-07-21 2020-10-27 复旦大学附属中山医院 基于大动脉炎肾动脉狭窄分级测定系统的测定方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4227454C1 (de) * 1992-08-19 1994-02-03 Henning Berlin Gmbh Verfahren zur Früherkennung, zur Erkennung des Schweregrads sowie zur therapiebegleitenden Verlaufsbeurteilung einer Sepsis sowie Mittel zur Durchführung des Verfahrens
DE19903336C2 (de) * 1999-01-28 2000-12-14 Brahms Diagnostica Gmbh Gebrauchsfertige Kalibratoren für die Bestimmung von Procalcitonin
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
EP1587955A4 (en) * 2002-12-24 2007-03-14 Biosite Inc DIFFERENTIAL DIAGNOSTIC MARKERS AND METHODS OF USE
US20050148029A1 (en) * 2003-09-29 2005-07-07 Biosite, Inc. Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
CA2485722A1 (en) * 2003-10-22 2005-04-22 Paul Lehmann Soluble transferrin receptor
ATE312351T1 (de) * 2004-02-13 2005-12-15 Brahms Ag Verfahren zur bestimmung der bildung von endothelinen zu zwecken der medizinischen diagnostik, sowie antikörper und kits für die durchführung eines solchen verfahrens
US20060024744A1 (en) * 2004-07-28 2006-02-02 Mills Rhonda A Methods for substantially simultaneous evaluation of a sample containing a cellular target and a soluble analyte
DE102004041659A1 (de) * 2004-08-27 2006-03-02 Institut Virion/Serion Gmbh Testvorrichtung für die in vitro Diagnostik von Multianalyt-Tests und deren Verwendung
US20070092911A1 (en) * 2005-10-03 2007-04-26 Buechler Kenneth F Methods and compositions for diagnosis and /or prognosis in systemic inflammatory response syndromes
CA2612450C (en) * 2005-06-28 2014-04-29 Zbx Corporation Membrane array and analytical device
DE102005034174A1 (de) * 2005-07-21 2007-02-08 B.R.A.H.M.S Ag Liquordiagnostisches in vitro Verfahren zur Diagnose von Demenz-Erkrankungen und neuroinflammatorischen Erkrankungen
WO2007103568A2 (en) * 2006-03-09 2007-09-13 Biosite, Inc. Methods and compositions for the diagnosis of diseases of the aorta
EP2020603A1 (en) 2007-08-03 2009-02-04 BRAHMS Aktiengesellschaft Method for risk stratification in stable coronary artery disease

Also Published As

Publication number Publication date
WO2009018979A1 (en) 2009-02-12
JP5385270B2 (ja) 2014-01-08
US9217742B2 (en) 2015-12-22
US20150087727A1 (en) 2015-03-26
ES2400022T3 (es) 2013-04-05
CN101932940B (zh) 2014-09-24
EP2185938A1 (en) 2010-05-19
EP2185938B1 (en) 2012-11-21
JP2010535330A (ja) 2010-11-18
US8735079B2 (en) 2014-05-27
US20160131664A1 (en) 2016-05-12
CN101932940A (zh) 2010-12-29
WO2009018979A9 (en) 2010-07-01
US9513301B2 (en) 2016-12-06
US20120122233A1 (en) 2012-05-17
EP2020603A1 (en) 2009-02-04
ES2369977T3 (es) 2011-12-09

Similar Documents

Publication Publication Date Title
HK1150176A1 (zh) 穩定性冠狀動脈疾病中的風險分級方法
HK1213761A1 (zh) 具有射線不可穿透的標誌物的支架
EP2069784A4 (en) IL-33 IN INFLAMMATORY DISEASE
IL202095A0 (en) Vascular stent
EP2013714A4 (en) FRAMEWORK FOR MODELING SUITES IN WORKFLOW
EP2040643A4 (en) STENT
EP2044907A4 (en) STENT
IL216137A0 (en) Implantation of repair chords in the heart
EP2118553A4 (en) LOAD-LOADING THREE-DIMENSIONAL STRUCTURE
EP2339986A4 (en) STENT
EP2241362A4 (en) FPD PARTIALLY WITHOUT JOINT
EP1974756A4 (en) STENT
IL183209A0 (en) Platform
TWI346309B (en) Method for reconstructing three dimension model
GB0706632D0 (en) New purine derivatives
EP2110103A4 (en) STENT
EP2136211A4 (en) PROCEDURE FOR ALLERGIC DISEASE
EP2121105A4 (en) FAST EXCHANGE CATHETER IMPROVED
EP2303187A4 (en) STENT USED IN A BLOOD VESSEL
HK1245693A1 (zh) 用於血液線路元件的可折疊組織器
EP2098195A4 (en) SELF-EXPANDING STENT
SG128644A1 (en) In vivo model for immunocomparability
EP2113029A4 (en) IN VIVO GENERAL MUTAGENESIS
PL2220256T3 (pl) Sposób diagnozowania in vitro raka skóry
EP2176761A4 (en) OBJECT MODEL FOR TRANSACTIONAL MEMORY